← Back to Search

Not Applicable

OKS for Gait Instability

N/A
Waitlist Available
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 5 minutes of oks
Awards & highlights

Study Summary

This study is evaluating whether optokinetic stimulation can improve gait abnormalities.

Eligible Conditions
  • Gait Instability
  • Vestibular Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 5 minutes of oks
This trial's timeline: 3 weeks for screening, Varies for treatment, and after 5 minutes of oks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gait - (measured using a wireless 3D accelerometer)
Posture - (measured using a stationary force platform)
Secondary outcome measures
Speed

Trial Design

1Treatment groups
Experimental Treatment
Group I: GaitExperimental Treatment1 Intervention
Patients undergoing a routine clinical gait assessment at the Brain Fit Club at BIDMC will have their posture and gait measured before and during optokinetic stimulation (OKS).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
OKS
2018
N/A
~20

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
836 Previous Clinical Trials
13,010,336 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025